Company / Return on Assets (ROA)
Vistagen Therapeutics, Inc. Return on Assets (ROA) History
FY2011-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-226.5%
FY2023
5-year range
-1272.0% / -19.2%
FY2019-FY2023
Trend
-842.5%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) changed -842% YoY in FY2023, a notable deviation from the 7-year average annual change of -1099%.
Based on SEC 10-K filings.
-226.5% in FY2023 with a 5-year CAGR of -135.6%.
Declined from -19.2% to -226.5% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -135.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2023, return on assets (roa) decreased 842.5% year-over-year.
- Peak return on assets (roa) was recorded in FY2021.
- Lowest return on assets (roa) in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2023 | -226.5% | -842.5% |
| FY2022 | -24.0% | -25.2% |
| FY2021 | -19.2% | +78.9% |
| FY2018 | -90.9% | +92.9% |
| FY2017 | -1272.0% | +73.7% |
| FY2014 | -4845.8% | -7069.3% |
| FY2012 | -67.6% | +0.0% |
| FY2011 | -67.6% | - |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026